Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

Journal of Cell Biology

Volumn 147, Issue 1, 1999, Pages 89-103

  Aguirre Ghiso, Julio A ^a   Kovalski, Katherine ^a   Ossowski, Liliana ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Fibronectin; Integrin activation; Mitogen activated protein kinase; Tumor dormancy; uPAR

Indexed keywords

FIBRONECTIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; UROKINASE RECEPTOR;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL DIVISION; CHICK EMBRYO; DOWN-REGULATION; ENZYME ACTIVATION; FIBRONECTINS; HUMANS; INTEGRINS; KINETICS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, FIBRONECTIN; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0002460807     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.147.1.89     Document Type: Article

References (49)

1. Andreasen, P.A., L. Kjøller, L. Christensen, and M.J. Duffy. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer. 72:1-22.
2. Bazzoni, G., L. Ma, M.L. Blue, and M.E. Hemler. 1998. Divalent cations and ligands induce conformational changes that are highly divergent among β1 integrins. J. Biol. Chem. 273:6670-6678.
3. Bohuslav, J., V. Horejsi, C. Hansmann, J. Stockl, U.H. Weidle, O. Majdic, I. Bartke, W. Knapp, and H. Stockinger. 1995. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181:1381-1390.
4. Busso, N., S.K. Masur, D. Lazega, S. Waxman, and L. Ossowski. 1994. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126: 259-270.
5. Chapman, H.A. 1997. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9:714-724.
6. Damsky, C.H., and Z. Werb. 1992. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr. Opin. Cell Biol. 4:772-781.
7. Dong, Z., R. Kumar, X. Yang, and I.J. Fidler. 1997. Macrophage-derived metalloelastase is responsible for the generation of angioslatin in Lewis lung carcinoma. Cell. 88:801-810.
8. Fazioli, F., M. Resnati, N. Sidenius, Y. Higashimoto, E. Appella, and F. Blasi. 1997. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO (Eur. Mol. Biol. Organ) J. 16: 7279-7286.
9. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med. 1:27-31.
10. Kim, J., W. Yu, K. Kovalski, and L. Ossowski. 1998. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 94:353-362.
11. Kirchheimer, J.C., J. Wojta, G. Christ, and B.R. Binder. 1987. Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB (Fed. Am. Soc. Exp. Biol.) J. 1:125-128.
12. Konakova, M., F. Hucho, and W.D. Schleuning. 1998. Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur. J. Biochem. 253:421-429.
13. Kook, Y.H., J. Adamski, A. Zelent, and L. Ossowski. 1994. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO (Eur. Mol. Biol. Organ) J. 13:3983-3991.
14. Lin, T.H., A.E. Aplin, Y. Shen, Q. Chen, M. Schaller, L. Romer, I. Aukhil, and R.L. Juliano. 1997. Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J. Cell Biol. 136:1385-1395.
15. Mainiero, F., C. Murgia, K.K. Wary, A.M. Curatola, A. Pepe, M. Blumemberg, J.K. Westwick, C.J. Der, and F.G. Giancotti. 1997. The coupling of α6β4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO (Eur. Mol. Biol. Organ) J. 16:2365-2375.
16. Marches, R., R.H. Scheuermann, and J.W. Uhr. 1998. Cancer dormancy: role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM. Cancer Res. 58:691-697.
17. May, A.E., S.M. Kanse, L.R. Lund, R.H. Gisler, B.A. Imhof, and K.T. Preissner. 1998. Urokinase receptor (CD87) regulates leukocyte recruitment via β2 integrins in vivo. J. Exp. Med. 188:1029-1037.
18. Mignatti, P., and D.B. Rifkin. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:161-195.
19. Miyamoto, S., H. Teramoto, J.S. Gutkind, and K.M. Yamada. 1996. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135:1633-1642.
20. Mortarini, R., A. Gismondi, A. Santoni, G. Parmiani, and A. Anichini. 1992. Role of the α5β1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin. Cancer Res. 52:4499-4506.
21. Murgia, C., P. Blaikie, N. Kim, M. Dans, H.T. Petrie, and F.G. Giancotti. 1998. Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin β4 cytoplasmic domain. EMBO (Eur. Mol. Biol. Organ) J. 17:3940-3951.
22. Nguyen, D.H., I.M. Hussaini, and S.L. Gonias. 1998. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J. Biol. Chem. 273:8502-8507.
23. Oka, H., Y. Chatani, R. Hoshino, O. Ogawa, Y. Kakehi, T. Terachi, Y. Okada, M. Kawaichi, M. Kohno, and O. Yoshida. 1995. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res. 55:4182-4187.
24. O'Reilly, M.S., L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:315-328.
25. Ossowski, L. 1992. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res. 52:6754-6760.
26. Ossowski, L., and E. Reich. 1983. Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell. 33:323-333.
27. Ossowski, L., G. Clunie, M.T. Masucci, and F. Blasi. 1991. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J. Cell Biol. 115:1107-1112.
28. Ploug, M., E. Ronne, N. Behrendt, A.L. Jensen, F. Blasi, and K. Dano. 1991. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266:1926-1933.
29. Porter, J.C., and N. Hogg. 1998. Integrins take partners: cross-talk between integrins and other membrane receptors. Trends Cell. Biol. 8:390-396.
30. Rabbani, S.A., A.P. Mazar, S.M. Bernier, M. Haq, I. Bolivar, J. Henkin, and D. Goltzman. 1992. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267:14151-14156.
31. Radeva, G., T. Petrocelli, E. Behrend, C. Leung-Hagesteijn, J. Filmus, J. Slingerland, and S. Dedhar. 1997. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem. 272: 13937-13944.
32. Ronne, E., N. Behrendt, V. Ellis, M. Ploug, K. Dano, and G. Hoyer-Hansen. 1991. Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor. FEBS (Fed Eur. Biochem. Soc.) Lett. 288: 233-236.
33. Schiller, J.H., and G. Bittner. 1995. Loss of the tumorigenic phenotype with in vitro, but not in vito passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha5/betal-integrin-fibronectin interaction. Cancer Res. 55:6215-6221.
34. Sier, C.F., R. Stephens, J. Bizik, A. Mariani, M. Bassan, N. Pedersen, L. Frigerio, A. Ferrari, K. Dano, N. Brunner, and F. Blasi. 1998. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res. 58:1843-1849.
35. Tang, H., D.M. Kerins, Q. Hao, T. Inagami, and D.E. Vaughan. 1998. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J. Biol. Chem. 273:18268-18272.
36. Toolan, H.W. 1954. Transplantable human neoplasms maintained in cortisone-treated laboratory animals: HS#1, H.Ep#1, H.Ep.#2, H.Ep.#3, and H.Emb.#1. Cancer Res. 14:660-666.
37. Varner, J.A., D.A. Emerson, and R.L. Juliano. 1995. Integrin α5β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol. Biol. Cell. 6:725-740.
38. Wang, F., V.M. Weaver, O.W. Petersen, C.A. Larabell, S. Dedhar, P. Briand, R. Lupu, and M.J. Bissell. 1998. Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl. Acad Sci. USA. 95:14821-14826.
39. Wary, K.K., F. Mainiero, S.J. Isakoff, E.E. Marcantonio, and F.G. Giancotti. 1996. The adapter protein She couples a class of integrins to the control of cell cycle progression. Cell. 87:733-743.
40. Wary, K.K., A. Mariotti, C. Zurzolo, and F.G. Giancotti. 1998. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 94:625-634
41. Wei, Y., M. Lukashev, D.I. Simon, S.C. Bodary, S. Rosenberg, M.V. Doyle, and H.A. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science. 273:1551-1555.
42. Wei, Y., X. Yang, Q. Liu, J.A. Wilkins, and H.A Chapman. 1999. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol. 144:1285-1294.
43. Werb, Z., P.M. Tremble, O. Behrendtsen, E. Crowley, C.H. Damsky. 1989. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109:877-889.
44. Wu, C., S.Y. Keightley, C. Leung-Hagesteijn, G. Radeva, M. Coppolino, S. Goicoechea, J.A. McDonald, and S. Dedhar. 1998. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J. Biol. Chem. 273:528-536.
45. Xue, W., A.L. Kindzelskii, R.F. Todd III, and H.R. Petty. 1994. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J. Immunol. 152:4630-4640.
46. Xue, W., I. Mizukami, R.F. Todd III, and H.R. Petty. 1997. Urokinase-type plasminogen activator receptors associate with β1 and β3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res. 57:1682-1689.
47. Yamada, K.M., and B. Geiger. 1997. Molecular interactions in cell adhesion complexes. Curr. Opin. Cell Biol. 9:76-85.
48. Yu, W., J. Kim, and L. Ossowski. 1997. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J. Cell Biol. 137: 767-777.
49. Zhao, J.H., H. Reiske, and J.L. Guan. 1998. Regulation of the cell cycle by focal adhesion kinase. J. Cell Biol. 143:1997-2008.